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Abstract 
Background: At the site of this quality improvement project, exclusive breast milk feeding rates 
before discharge from a newborn nursery were behind benchmark goals.  The aim of this project 
was to improve exclusive breast milk feeding rates by implementing a Pasteurized Donor Human 
Milk (PDHM) Program for breastfeeding newborns requiring medically indicated 
supplementation.  The study site was a Level I newborn nursery of a 20-bed, labor, delivery, 
recovery, and postpartum unit within a 100-bed community hospital (i.e., the agency). 
Methods:  This retrospective pre-post cohort study used the Plan, Do, Study, Act (PDSA) 
framework for rapid cycle change to assess the impact of the program on breast milk feeding 
exclusivity on discharge.  The primary outcomes of interest were on the change in exclusivity 
among the full-term population according to the Joint Commission’s Perinatal Care Core 
Measures PC-05 and PC-05a (retired).  Variables of interest included the hour of newborn age at 
first supplementation, indications for supplementation, and formula use in the breastfeeding 
population within the first two days of life.  Data were collected by abstraction and medical 
record review for 3 months pre- and 3 months post- PDHM Program implementation. 
Interventions: A multi-disciplinary team was developed to plan and implement the PDHM 
Program.  The process began by developing necessary documents and workflows and ended with 
staff training and safe provision of PDHM. 
Results:  Three months after implementation, exclusive breast milk feeding rates increased 3% 
(pre- 68%, post- 71%) in the full-term population and 11% (pre- 77%, post- 88%) within the full-
term, breastfeeding population. 
Conclusions:  The implementation of a PDHM Program was successful in improving exclusive 
breast milk feeding rates.  Exclusive breast milk feeding rates exceeded the intended 10% 
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increase based on the PC-05a metric.  While many successes were realized in this quality 
improvement project, further work is needed to better grasp the impact of a PDHM Program at 
the agency and the implications of using PDHM in the full-term population. 
Keywords:  baby-friendly, baby-friendly hospital initiative, breastfeed, breast feed, breastfed, 
donor, donor milk, donor human milk, exclusive, exclusive breastfeeding, formula, human, 
human milk, infant formula, milk 
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Implementation of Donor Human Milk in a Newborn Nursery: 
A Quality Improvement Initiative to Increase 
Exclusive Breast Milk Feeding 
Problem Description 
Based on extensive empirical evidence, many leading health organizations including the 
World Health Organization (WHO, 2017), American Academy of Pediatrics (AAP, 2012), and 
Academy of Breastfeeding Medicine (ABM, 2017) recommend exclusive breastfeeding for the 
first 6 months of life with continued breastfeeding for a minimum of 1-2 years.  The Centers for 
Disease Control and Prevention (CDC) report exclusive breastfeeding rates based on data from 
the National Immunization Survey (NIS) which also informs the Maternal, Infant, and Child 
Health metrics on exclusive breastfeeding for HealthyPeople 2020 (2017).  Breastfeeding 
initiation and exclusive breastfeeding rates at 3 months and 6 months were reported in 2014 as 
82.5%, 46.6% and 24.9% respectively (CDC, 2017).  This significant drop in exclusive 
breastfeeding rates over the first 6 months of life may indicate that women are not receiving the 
education or support needed to achieve the recommended duration of exclusive breastfeeding 
(CDC, 2017). 
Available Knowledge 
 Breastfeeding Support 
Evidence-based strategies to support breastfeeding are broad.  Examples include prenatal 
education, limiting infant formula marketing, and family, professional, peer, and workplace 
postpartum support.  While each strategy plays a role in breastfeeding success, what follows is a 
discussion of available knowledge focused on the role of breastfeeding support in the inpatient 
setting. 
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The WHO and United Nations International Children’s Emergency Fund (UNICEF) have 
been gathering evidence and promoting best practices in breastfeeding support for decades.  In 
1981 (UNICEF & WHO) the International Code of Marketing of Breast-Milk Substitutes (The 
Code) was released representing one of the first global strategies to support breastfeeding.  The 
Code prohibits purveyors of breastmilk substitutes from public advertising, provision of samples, 
or direct contact with pregnant women or mothers with young children (UNICEF & WHO, 
1981).  In 1990, UNICEF established the Innocenti Declaration calling for organizations and 
governments to recognize, protect, promote, and support breastfeeding.  Subsequently, in 1998 
the WHO published evidence-based maternity practices that support breastfeeding called the 
“Ten Steps to Successful Breastfeeding” (Ten Steps) which are presented in Table 1. 
Table 1 
The Ten Steps to Successful Breastfeeding 
1. Have a written breastfeeding policy that is routinely communicated to all health care staff. 
2. Train all health care staff in the skills necessary to implement this policy. 
3. Inform all pregnant women about the benefits and management of breastfeeding. 
4. Help mothers initiate breastfeeding within one hour of birth. 
5. Show mothers how to breastfeed and how to maintain lactation, even if they are separated from their 
newborns. 
6. Give newborns no food or drink other than breast-milk, unless medically indicated. 
7. Practice rooming in - allow mothers and newborns to remain together 24 hours a day. 
8. Encourage breastfeeding on demand. 
9. Give no pacifiers or artificial nipples to breastfeeding newborns. 
10. Foster the establishment of breastfeeding support groups and refer mothers to them on discharge 
from the hospital or birth center. 
Note. Table information is from Baby-Friendly USA (n.d.). 
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The Ten Steps focus on the importance of maternity care practices in improving 
breastfeeding outcomes and are widely accepted as the best evidence-based practices to support 
breastfeeding.  The Ten Steps continue to be well supported by organizations including the AAP 
and ABM, among many others (Baby-Friendly USA, n.d.).  In 2009, UNICEF and WHO 
released The Baby-Friendly Hospital Initiative (BFHI) to encourage, and recognize through 
designation, birthing facilities that follow the Ten Steps to Successful Breastfeeding (UNICEF & 
WHO, 1998) and The Code (UNICEF & WHO, 1981) globally. 
 Positive outcomes of the BFHI are repeatedly reported in the literature.  The PROBIT 
study was a hallmark cluster-randomized trial of over 17,000 subjects concluding that BFHI 
practices and the Ten Steps had a positive impact on exclusive breastfeeding rates in the first 
year of life (Kramer et al, 2001).  While BFHI designation does not appear to effect 
breastfeeding outcomes (Patnode, Henninger, Senger, Perdue & Whitlock, 2016), evidence 
shows that implementing some or all of the Ten Steps has a positive, dose-response on 
breastfeeding (Kramer et al., 2001; Perez-Escamilla, Martinez, Segura-Perez, 2016).  In other 
words, implementation of only a portion of the Ten Steps may still translate into positive patient 
breastfeeding outcomes.  The goal of this project, at what will heretofore be referred to as the 
study agency, was to address Step 6, “Give no food or drink other than breast milk,” (Baby-
Friendly USA, n.d.) and improve exclusive breastfeeding before discharge by implementing a 
Pasteurized Donor Human Milk (PDHM) program. 
Exclusive Breast Milk Feeding 
While the general definition of breastfeeding is inconsistent or lacking in some evidence, 
the AAP, WHO, and Joint Commission (JC) broadly agree on definitions of exclusive 
breastfeeding defined as: the provision of only breastmilk from birth and allows for vitamins, 
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minerals and medicines as needed (JC, 2017; National Institute of Child Health and Human 
Development [NICHD], 2017).  By this definition, newborns are still considered exclusively 
breastfed whether they feed directly at breast, receive their expressed mother’s own milk, or 
donor human milk.  Breastfed newborns who receive infant formulas, glucose water, water, or 
solid food are no longer considered exclusively breastfed regardless of the medical indication, or 
lack thereof.  The early use of formula supplementation in the breastfed newborn increases the 
newborn’s risk of infection (Kramer & Kakuma, 2012), early cessation of breastfeeding 
(Chantry, Dewey, Peerson, Wagner, & Nommsen-Rivers, 2014; Demirci & Bogen, 2017; Parry, 
Ip, Chau, Wu, & Tarrant, 2013), and alters the newborn gut microbiome with the potential to 
impact long term metabolic health outcomes (Azad et al., 2013; Bokulich et al., 2016; Johnson & 
Versalovic, 2012; Luerou-Luron, Blat & Boudry, 2010; Madan et al., 2016; Wampach et al., 
2017).		 
The literature strongly supports that the lack of breastfeeding in the newborn and infant 
populations leads to morbidity and mortality in infancy through adulthood.  The AAP (2012) 
reported dose-response risk reductions for breastfed newborns for the following conditions: otitis 
media, respiratory tract infections, asthma, atopic dermatitis, gastroenteritis, inflammatory bowel 
disease, cardiovascular disease in adulthood, obesity in adolescence and adulthood, celiac 
disease, type I and type II diabetes, leukemia, sudden infant death syndrome (SIDS), and 
necrotizing enterocolitis (NEC) in preterm infants.  Mixed results in some outcomes have been 
identified, such as for asthma and allergies, yet the evidence clearly supports improved health 
outcomes overall (AAP, 2017; Dietrich et al., 2013; Ip et al., 2007).  Dietrich et al. (2013) report 
outcomes from a 1999 study by Ball and Wright indicating that for 1,000 infants who exclusively 
breastfed for 3 months vs 1,000 infants who never breastfed, the healthcare system would see a 
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reduction of 2,033 office visits, 212 hospital days, and 609 prescriptions in the first year of life 
alone.  Equally as important, are the negative outcomes in a dose-response relationship for 
mothers who do not breastfeed.  These mothers have an increased risk of type II diabetes, 
postpartum depression, breast cancer, ovarian cancer, and cardiovascular disease (Ip et al., 2007; 
Chowdhury et al, 2015; Dietrich et al., 2013). 
To reduce the risk of morbidity and mortality, one approach to supporting early exclusive 
breastfeeding is to avoid supplementation of breastfed newborns unless medically indicated 
(AAP, 2012; ABM, 2017; International Lactation Consultant Association [ILCA], 2014).  The 
ABM (2017) lists possible medical indications for supplementation: hypoglycemia, signs and 
symptoms of insufficient milk intake (i.e., dehydration, weight loss, insufficient voids and 
stools), hyperbilirubinemia, inborn errors of metabolism, delayed onset of maternal milk supply, 
glandular insufficiency of the breast, breast pathology or past surgery, contraindicated maternal 
medication use, temporary separation of the dyad, or intolerable maternal pain during feeding 
unresolved by intervention. When supplementation of a breastfed newborn is medically 
necessary, and the mother’s milk is insufficient or unavailable, donor human milk is the 
preferred alternative (WHO, 2017).  Most organizations, have made the further distinction to 
recommend pasteurized donor human milk (PDHM) to reduce potential exposure of newborns to 
diseases and contaminants (ABM, 2017; AAP, 2017; Association of Women’s Health, Obstetrics 
and Neonatal Nurses [AWHONN], 2015; ILCA, 2014).  Rates of early formula use in breastfed 
newborns are decreasing nationally; however, rates in the agency under study remain high (CDC, 
2017).   
A divide exists among leading organizations that promote the use of PDHM as the next 
best alternative to a mother’s own milk when supplementation is necessary.  Some organizations 
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and statements, such as the AWHONN statement (2015), and Surgeon General’s Call to Action 
to Support Breastfeeding (U.S. Department of Health and Human Services [U.S. DHHS], 2011), 
recommend PDHM as the next best alternative to a mother’s own milk specifically for fragile 
newborns (e.g., premature, low birth weight, critically ill) while not making exclusionary 
comments on its use for other newborn populations.  However, other organizations, such as the 
AAP (2012), ABM (2017), and ILCA (2014) support PDHM as the next best alternative to a 
mother’s own milk without distinction to population.  The dichotomy stems in part from a 
historically limited supply for the existing demand thus to preserve the supply for those in 
greatest need.  In 2008 milk banks in the U.S. distributed 1.4 million ounces of PDHM yet the 
need for just the low birth weight newborn population (<1,500 g) at that time was approximately 
9 million ounces (U.S. DHHS, 2011).  However, PDHM availability and use is at a record high.  
In 2018, Human Milk Banking Association of North America (HMBANA) reported nearly 6 
million ounces, from 10,000 donors, were distributed from 27 HMBANA member milk banks in 
the U.S. and Canada in 2017 (Groff, 2018).  These increases are also reflected in Perrin’s (2018) 
report of a 74% increase in the use of PDHM among Level II to Level IV neonatal care hospitals 
since 2011 when the Surgeon General’s Call to Action was released.  While the inequality of 
supply and demand for PDMH exists, so does a lack of clinician and payor knowledge about 
PDMH and a lack of policies to regulate and support the use of PDHM (U.S. DHHS, 2011).  
Despite the reported disparity in access to PDHM, local hospitals that are obtaining PDHM 
through a regional milk bank accredited by HMBANA, called Mothers’ Milk Bank Northeast 
(MMBNE), have found an abundant supply and have begun offering PDHM to healthy newborn 
populations.   
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Donor Milk’s Impact on Exclusivity 
At the time of this project, 10 hospitals in NH were using PDHM from Level I nurseries 
to Level III NICU’s (New Hampshire Breastfeeding Task Force [NHBFTF], 2017).  There is 
strong evidence and wide-spread support for the use of PDHM in the NICU setting due to its 
significant reduction in certain morbidities, such as necrotizing enterocolitis (NEC), which are 
almost exclusively experienced by the preterm population (AAP, 2012; ABM, 2017; AWHONN, 
2015; U.S. DHHS, 2011).  Additionally, the preterm population is at higher risk of experiencing 
several breastfeeding challenges such as low maternal milk supply, inability to directly 
breastfeed, and the potential for multiple comorbidities and interventions all which may 
negatively impact exclusive breastfeeding.  Therefore, the results of these prior studies may not 
be generalizable to the full-term newborn population.   
The body of evidence on the impact of PDHM on exclusive breastfeeding rates in the 
late-preterm and full-term newborn population is extremely limited.  The use of PDHM in the 
healthy newborn population is a more recent development driven in part by statements from the 
AAP and ABM that PDHM is the best alternative to a mother’s own milk.  Additionally, quality 
metrics such as the JC’s (PC-05) Exclusive Breast Milk Feeding, which does not discretely 
account for PDHM in establishing exclusivity and applies only to the full-term population, are 
driving birthing facility decisions and policies related to newborn feeding.  The University of 
Iowa’s Children’s Hospital has been offering PDHM to term and late-preterm populations for 
over a decade and report that provision of PDHM may promote exclusive breastfeeding (Kair, 
Colaizy & Hubbard, 2014; Kair & Flaherman, 2017).  A 2018 survey of northeastern hospitals, 
found that 32% of hospitals provided PDHM to healthy newborns (Belfort, 2018).  Based on the 
JC’s Exclusive Breast Milk Feeding (PC-05) metric, hospitals that provided PDHM to healthy 
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newborns had a 77% exclusive breast milk feeding rate at discharge compared to only a 56% at 
hospitals who do not offer this option (Belfort, 2018).   
Sen et al. (2018) at Brigham and Women’s Hospital in Boston, MA examined the trends 
in PDHM use in their hospital for the healthy newborn population and found increasing 
utilization over a 3 year period.  The authors advise caution as there is little known about the 
benefits and risks of PDHM use in this population (Sen et al., 2018).  It is well documented that 
early formula supplementation has a negative effect on maternal breastfeeding confidence and 
maternal milk supply which create a cycle of increasing supplementation which continues to 
negatively impact confidence and supply and ultimately results in early breastfeeding cessation 
(Sen et al., 2018).  The concern has been raised whether the provision of PDHM may establish a 
similar cycle.  One study in the preterm population concluded that the use of PDHM may 
decrease the provision of a mother’s own milk which would have implications for the duration of 
exclusive or any breastfeeding (Williams, Nair, Simpson & Embelton, 2016).  However, multiple 
studies found positive outcomes regarding PDHM use on exclusivity before discharge in the 
preterm population (Marinelli, Lussier, Brownell, Herson, & Hagadorn, 2014; Utrera Torres, 
2010). 
Based on available supply and significant costs, PDHM in the healthy newborn is often 
seen as a “bridge” to support short-term medically indicated nutritional needs of a breastfed 
newborn until the onset of lactogenesis II and copious milk supply.  In a qualitative study by 
Kair and Flaherman (2017), mothers viewed PDHM as temporary whereas formula was viewed 
as an ongoing plan.  This paradigm for the temporary use of PDHM when supplementation is 
medically necessary may help decrease the risk of mothers experiencing the negative cycle 
IMPLEMENTING DONOR HUMAN MILK 13 
leading to early breastfeeding cessation, as seen with early formula supplementation; and may be 
a contributing factor to the ultimate return to exclusively providing a mother’s own milk.   
Benchmark Reporting 
Benchmark reports exist related to exclusive breast milk feeding in the inpatient setting.  
Differences in how data are collected, measured, and reported are evident among organizations 
that benchmark and report exclusive breast milk feeding including HealthyPeople 2020, the JC, 
mPINC, the Breastfeeding Report Card, and the BFHI.  This can make comparing exclusive 
breastfeeding rates and practices among birthing facilities challenging for both laypeople and 
staff.   
HealthyPeople 2020 (2017) set a goal to reduce the proportion of breastfed newborns 
who receive formula supplementation in the first 2 days of life from the current 17.1% to 14.2% 
(CDC, 2016).  Alternatively, the JC developed quality metrics in perinatal care to support 
improvements in patient safety and effectiveness of care called the “Perinatal Care Core Measure 
Set” (JC, 2017).  The PC-05 metric is related to newborn feeding and measures the proportion of 
full-term inpatient newborns fed only breast milk before discharge (JC, 2017).  The JC reported a 
2016 national rate of exclusive breast milk feeding of 52.9% (JC, 2017).  Unlike the 
HealthyPeople 2020 goal, the PC-05 measure includes newborns of families who have chosen to 
formula feed and newborns for whom breastfeeding is contraindicated based on maternal factors.  
Historically, the JC attempted to collect breast milk feeding data based on feeding choice (PC-
05a) and excluded patients for whom breastfeeding was contraindicated by maternal factors.  
These subsets and exclusions were deemed too difficult for hospital data abstractors and were 
ultimately retired.  In a 2015 publication the JC acknowledges the impact of family preference 
and states that they, “…expect that performance on PC-05 will remain well below 
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100%...Available evidence suggests that a performance rate of 70% on PC-05 is an achievable 
target for hospitals to strive to achieve” (JC, 2015).  
The CDC (2015) reports state and national survey data on maternity practice measures in 
a report called “Maternity Practices in Newborn Nutrition and Care” (mPINC).  In the mPINC 
survey, hospitals are asked “what percent of healthy breastfed newborns receive non-breast milk 
feedings” (CDC, 2015).  The CDC reports that nationally, 27% of hospitals replied <10%, 53.7% 
of hospitals replied 10-49%, 17.1% replied 50-89%, and 2.2% of hospitals replied 90% or more.  
In NH, 55.6% of hospitals replied that <10% of healthy breastfed newborns receive non-breast 
milk feedings and the remainder fall into the 10-49% category, including the study agency 
(CDC, 2015).  The CDC ranks states on the overall mPINC findings with NH ranking 2nd 
nationally.  With the state providing some of the highest quality inpatient practices in maternity 
care and newborn feeding nationally, the study agency must meet high standards to remain 
competitive. 
The CDC (2016) also produces the Breastfeeding Report Card which reports state-based 
data according to HealthyPeople 2020 goals.  In 2014, NH’s rates of breastfeeding initiation and 
exclusive breastfeeding at 3 months and 6 months were 82.5%, 46.6% and 24.9% respectively 
(CDC, 2017).   Of particular interest were the national and NH state specific rates of breastfed 
newborns receiving formula before 2 days of age which were 17.1% and 6.6% respectively 
(CDC, 2016). 
Hospitals designated through the Baby-Friendly Hospital Initiative, or that are aiming to 
follow the “Ten Steps to Successful Breastfeeding”, follow the “Guidelines and Evaluation 
Criteria” (2016) set forth by the Baby-Friendly Hospital Initiative.  Criteria for Step 6, “give 
newborns no food or drink other than breast milk, unless medically indicated”, advises facilities 
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to reach for the HealthyPeople 2020 goals related to exclusivity (Baby-Friendly USA, 2016).  
The Guidelines also advise facilities to compare the rate of non-medically indicated 
supplementation to the annual supplementation rate reported by the CDC’s NIS data in the 
facility’s region (Baby-Friendly USA, 2016).  The BFHI (2016) requires at least 80% of 
breastfeeding mothers report exclusive breastfeeding at discharge, supplementation for a 
medically acceptable reason based on current evidence, or supplementation by parental request.  
If a parent requests supplementation, at least 80% should have documented education on the 
negative impact of non-breast milk feedings, and the facility’s rate of non-medically indicated 
supplementation is required to decrease annually (Baby-Friendly USA, 2016). 
Rationale 
The rationale behind the use of PDHM in the healthy newborn population is multifaceted.  
PDHM is the recommended alternative to a mother’s own milk when supplementation is 
medically necessary (AAP, 2012; ABM, 2017; ILCA, 2014; WHO, 2003) and its use aligns with 
Step 6 of the BFHI (Baby-Friendly, USA, n.d.).  Evidence strongly suggests that protecting the 
breastfeeding relationship through early maternity practices that support exclusive breastfeeding 
improves breastfeeding related outcomes such as duration and exclusivity of breastfeeding 
(BFHI, 2016; DiGirolamo, 2008; WHO, 2009).  This is exceptionally important as suboptimal 
breastfeeding increases the risks of morbidity and early mortality for both mothers and children 
(Bartick, 2017). 
Second, it has been shown that early formula supplementation results in a nearly three-fold 
increased risk of breastfeeding cessation by 2 months of age (Chantry et al, 2014).  However, 
most positive maternal and newborn health outcomes from breastfeeding are realized with a 
minimum of 3 months of breastfeeding with a dose-response effect (AAP, 2012; Bartick et al, 
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2017; Stube et al, 2017).  Focused initiatives to improve maternity practices in support of 
breastfeeding may have a direct impact on the health benefits to both mothers and children. 
Third, data have been available for decades on the impacts of breastfeeding and formula 
feeding on the health and development of the newborn gut (Le Huerou-Luron, Blat & Boudry, 
2010; Wang, 2016; Wampach et al., 2017).  More recent studies are finding that human milk is 
composed of beneficial bacteria and human milk oligosaccharides (HMO’s).  HMO’s, the third 
largest component of human milk, are prebiotics to promote beneficial flora while inhibiting 
pathogenic bacterial binding (Davis, 2016).  Formula use decreases bacterial diversity and 
increases the proportion of potentially pathogenic bacteria such as C.difficile (Davis, 2016; 
Wang, 2016).  The resulting dysbiosis, also impacted by other variables such as mode of delivery 
and antibiotic use, has the potential for negative long-term outcomes via immune-modulated and 
metabolic diseases (Wang, 2016). 
Finally, quality improvement measures, such as the JC’s PC-05 on Exclusive Breast Milk 
Feeding and mPINC, are driving birthing facilities to examine their current practices and strive 
to make evidence-based improvements that support breastfeeding (CDC, 2015; JC, 2017).  These 
types of benchmarks and reports related to exclusive breast milk feeding may also have a 
financial impact on birthing facilities.  Patient satisfaction related to breastfeeding policies and 
care, ability to achieve BFHI designation, and the impact of suboptimal breastfeeding on 
morbidity and mortality each play a financial role for birthing facilities. 
Specific Aim 
The specific aim of this quality improvement initiative was to implement a PDHM 
program at a single, community hospital with the goal of improving exclusive breastfeeding rates 
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by 10% according to the JC’s Exclusive Breast Milk Feeding measure (PC-05) within 3 months 
of implementation (JC, 2017). 
Methods 
Context 
The agency is a 100-bed, Magnet designated hospital serving the NH seacoast 
community and is affiliated with other local healthcare services such as a visiting nurse 
association and multiple outpatient providers.  The agency’s Family Center is a 20-bed labor, 
delivery, postpartum, recovery, and pediatric unit with a designated operating room, antenatal 
room, and Level I nursery.  The nursery supports stable newborns of 35 completed weeks of age 
and older.  The Family Center has approximately 650 births per year and is staffed with 
Registered Nurses, Clinical Practice Leaders, Obstetrical Technicians, and Lactation 
Consultants.  Additional routine clinical providers include: obstetricians, midwives, 
pediatricians, and family practice physicians.  Currently, approximately one-half of births in NH 
occur in a BHFI designated facility (NHBFTF, 2017). Notably, the agency is neither designated 
as a BFHI facility nor on the path toward designation.  However, it is the agency’s goal at the 
time of this report to align with nine of the Ten Steps. 
Intervention 
Process. 
The intervention was to develop and implement a PDHM Program in a Level I newborn 
nursery aimed to positively impact exclusive breastfeeding rates in the healthy newborn 
population.  Stakeholder buy-in and an environment to support the use of PDHM was established 
over 1 year prior to the renewed efforts to implement the program.  The delay was related to a 
change in leadership, lengthy process to procure and install a freezer for PDHM, and lack of 
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available time by staff to maintain project momentum.  In September 2017 a multidisciplinary 
team was established to implement the project.  The Donor Milk Team (Team), was formed to 
have a broad range of perspective in the planning and actualization of the project and included 
the Team Leader, Pediatric Medical Director, Obstetric Medical Director, maternal-child Clinical 
Practice Leader, inpatient Lactation Coordinator, midwife, day-shift staff nurse, night-shift staff 
nurse, and Quality Coordinator.  The Team met face-to-face initially, then collaborated 
electronically and via smaller face-to-face meetings periodically.  The purpose of the Team’s 
collaboration was to plan the steps, develop and approve documents, develop and provide 
education to staff, and ultimately bring the PDHM project from initial stakeholder approval to 
post-intervention sustainability. 
 Agency groups outside of the core Team were also part of the process: the Maternal-
Child unit Director for approval of all documents and workflows, the Patient Care Standards 
Committee for policy approval, the Legal Department for informed consent final approval, the 
Document Control team for processing all forms to be available electronically to staff, and 
Information Technology for private folder creation to facilitate the Team’s communication and 
accessibility to the most current documents.  The Director of Client Relations at MMBNE, the 
regional milk bank accredited by HMBANA, was also integral in the planning stage of the 
project to ensure all necessary guidelines and procedures were met to comply with the safe 
management of PDHM in the hospital setting.  MMBNE also enrolled the Team Leader in a 
ListServ of hospitals who offer, or are in the process of implementing, PDHM as an outside 
source of support for the project. 
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The Plan, Do, Study, Act (PDSA) framework for rapid cycle change was used in this 
quality improvement project (Institute for Healthcare Improvement, 2018).  One full cycle was 
completed at the time of this report as follows.   
Plan. 
The Team began by meeting and planning the necessary steps and gathering key 
stakeholders for the project.  The first goals were to create and obtain approval for the necessary 
documents to support a PDHM program including a policy, consent form, and patient education 
handout.  Six hospitals in the region that already used PDHM were contacted and asked if they 
would share their existing documents related to PDHM.  All hospitals willingly shared 
information which helped guide the Team’s creation and approval processes. 
Do. 
Establishing a Milk Bank Account.     
The Team assisted the agency in establishing an account with MMBNE.  Workflows 
were developed in coordination with MMBNE for ordering, maintaining, feeding, and tracking 
the use of PDHM.  An additional program offered by MMBNE for patients who are using 
PDHM at discharge and wish to purchase a supply for home use was implemented concurrently 
with the use of PDHM on the unit.  This Replacement Agreement program required the use of 
additional documents from MMBNE and a workflow for sending patients home with a small 
supply of PDHM from the stock at the agency and a means of reimbursement from the patient to 
the agency for that PDHM. 
Creating the Environment. 
 A hardwired, alarming freezer and refrigerator were installed and designated solely for 
PDHM prior to the start of this project.  During the project, Facilities staff assisted in calibrating 
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the freezer to meet HMBANA specifications and calibrating tap water temperatures to facilitate 
milk thawing and warming in the PDHM area.  Containers to hold water for the warming of 
PDHM, as well as oral syringes, spoons, cups, finger feeders, and supplemental nursing systems 
(SNS) for individual feedings, were already available on the unit.  A resource binder with all 
PDHM related documents, a log for the receipt and delivery of PDHM, and packets of patient 
documents necessary to initiate PDHM were stocked in the PDHM area to streamline workflow 
for staff.   
Educating Staff. 
The Team Leader developed staff education which was provided electronically and 
through face-to-face poster presentation training sessions.  Four live sessions were executed at 
various times within the 2 weeks prior to the implementation date.  All staff received the 
training: nurses, Lactation Consultants, pediatricians, obstetricians, midwives, family practice 
providers, Obstetrical Technicians, and Unit Coordinators.  The education included the policy, 
workflow, related documents, and resources for families and staff.  The Lactation staff required 
deeper understanding as they would become resources to all staff and responsible for 
maintaining the supply of PDHM and processing Replacement Agreements.  Targeted education 
was provided directly to all Lactation staff. 
 PDHM Tracking Process. 
 An account was established with MMBNE, in conjunction with the agency’s Purchasing 
Department, to establish a standing purchase order enabling the Team Leader and Lactation staff 
to place orders directly with MMBNE.  The initial stock of PDHM was ordered by the Team 
Leader and subsequently maintained by the Lactation staff.  The initial order of seven 100 ml 
bottles and three 50 ml bottles was based on MMBNE’s recommendation.  Subsequent orders 
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were based on actual usage by the inpatient families and families sent home with PDHM.  Upon 
receipt of PDHM, it was logged with receipt date, volume, batch numbers, and expiration date.  
Any PDHM received as a Replacement Agreement for PDHM previously sent home with a 
family was also logged with receipt date, volume, name and medical record number of the 
newborn associated with that order. 
 Provision of PDHM. 
 The Team developed the following criteria for PDHM supplementation eligibility. 
1. The mother must have chosen to breastfeed with the absence of contraindications to 
breastfeeding. 
2. The newborn must have at least one medical indication for supplementation: preterm or 
late preterm gestation, large or small for gestational age, hypoglycemia, 
hyperbilirubinemia, excessive weight loss, implementation of a Lactation Feeding Plan, a 
medically compromised mother (e.g., the mother was in the intensive care unit [ICU] or 
experienced a postpartum hemorrhage), or at the newborn’s provider’s discretion. 
3. Maternal milk must be unavailable or insufficient to meet the newborn’s need. 
4. An order for PDHM must be obtained from the newborn’s provider.  Volumes of any 
supplement given to a breastfed newborn, including PDHM, are based on the average 
newborn intake volumes established by the ABM (2017). 
 Four months after the team’s first meeting, in January 2018, PDHM was first ordered and 
became available to the patients.  The Team Leader was on-site frequently in the first 3 weeks to 
assist staff and answer questions.  Small improvements to workflow were made on an ongoing 
basis guided by direct feedback from nursing and lactation staff. 
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Families of newborns who met criterion to receive PDHM were educated verbally and in 
writing about the use of PDHM and its alternative, formula, to facilitate informed decision 
making.  Parents had the opportunity to have all their questions answered to their satisfaction.  
Regardless of the type of supplement chosen, families continued to receive the standard level of 
care.  Families who chose to use PDHM received the PDHM Patient Education sheet and signed 
the PDHM Informed Consent prior to supplementation.  Details about the feeding, including 
batch number and signed consent, were documented in the electronic medical record (EMR).  
Hard copy documents were placed in the newborn’s chart. 
Study. 
The Team Leader was responsible for data collection.  Pre- and post- quantitative data 
were collected using a retrospective medical record review for the 3 months prior to PDHM 
implementation and 3 months after implementation. With the guidance of a graduate student 
statistician approved by the agency’s IRB, data were analyzed.  Ongoing data collection on 
exclusive breast milk feeding rates by the agency will continue and help to inform future quality 
improvements.  Details about the measures, analysis and results of the study are detailed in the 
following sections. 
Act. 
The Team Leader assisted staff during the first 3 months post-implementation.  This 
allowed for opportunities to reinforce staff teaching and better understand challenges in the 
process.  Small changes in the workflow were made based on feedback from the staff.  For 
example, RN’s were required to manually log each PDHM feeding and document it in the EMR.  
This was a failsafe to ensure the batch number of each feeding was being captured which is 
critical in the event of a recall.  However, after confirmation of consistently appropriate 
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electronic documentation by staff, the written log was discontinued.  Also, RN’s and Lactation 
Consultants who work directly with the process of thawing, warming and feeding PDHM 
expressed a lack of efficiency in the time and attention required in the thawing and warming 
processes.  Discussions with the Director of the unit to obtain a commercial grade warmer were 
ongoing, though the unit’s budget did not allow for the purchase of a warmer until the next 
budget cycle in late 2018.  As a result, renewed efforts for outside funding were explored and 
ultimately secured.  At the time of this report, the unit is awaiting receipt of the milk warmer.  
Education and new workflows will be put in place with the aim of streamlining the process for 
staff and improving access to PDHM for those in need. 
Study of the Intervention 
The metrics established by the JC in their Perinatal Core Measure of Exclusive Breast 
Milk Feeding measures (PC-05 & PC-05a) were used to assess the impact of the intervention on 
the primary variable of interest, exclusive breast milk feeding.  Descriptive statistics were used to 
express clinical trends of interest among additional variables including: hour of age at first 
supplementation, indications for supplementation, and formula supplementation of breastfed 
newborns in the first 2 days of life.  Pearson’s chi-square was used to determine whether an 
association existed between implementation of PDHM and exclusive breast milk feeding with 
statistical significance established at p = < 0.05.   
Measures 
Breastfeeding exclusivity was measured based on the Joint Commission’s (JC) Perinatal 
Core Measure on Exclusive Breast Milk Feeding (PC-05) and Exclusive Breast Milk Feeding 
Considering Mother’s Initial Feeding Plan (PC-05a) (JC, 2017; Milton, 2015).  Medical records 
of all newborns born at the study agency during the study period were included in data 
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abstraction.  The JC (2017) provides definitions and data requirements for population inclusion, 
exclusion, data collection elements, and proper calculations for PC-05.  While PC-05a is a retired 
metric, it was used by the JC to calculate exclusive breast milk feeding metrics based on the 
mother’s feeding choice on admission.  Notably, at the time that PC-05a was retired, exclusion 
criteria included maternal indications for contraindications to breastfeeding along with those 
currently used for PC-05 calculations.  For the purposes of this report, exclusions for calculating 
PC-05a were based on the same exclusions currently used for PC-05 which do not exclude 
maternal contraindications to breastfeeding.  Exclusion criteria included gestational age less than 
37 completed weeks, multiple gestation, transfer to another hospital, diagnosis of galactosemia, 
receipt of parenteral nutrition, death, or length of stay greater than 120 days.  The validity and 
reliability of the measure tools (PC-05 & PC-05a) are not documented.   Despite this, the PC-05 
tool is used by JC accredited facilities, the Centers for Medicare and Medicaid Services 
(CMS9v6), insurers, and among others. 
Data were abstracted and manually collected from the medical records.  Patient 
identifiers were removed from the aggregate data.  Aggregate data were entered and managed in 
Excel 16.12 (Excel).  Analyses via descriptive statistics in Excel and Pearson’s chi-square in 
OpenEpi 3.01 (Dean, Sullivan & Soe, 2006) for exclusive breast milk feeding outcomes before 
and after project implementation were completed.  Promotion of data accuracy was based on 
redundancies in data collection from multiple locations, spot checks, and comparisions of data 
with the agency’s Quality department.  Data were initially abstracted from Midas (Conduent 
Health Analytics Solutions, 2012), the agency’s reporting system.  Additional data were 
collected from the agency’s electronic medical records system called Meditech (Medical 
Information Technology, Inc., 2015), hard copy delivery log for the unit, and hard copy lactation 
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department documentation.  Spot checks of data were compared among available data sources 
for accuracy.  Completeness was ensured by the Team Leader’s review of data to ensure no 
missing values were present. 
Analysis 
Pre-intervention and post-intervention cohorts were analyzed using a Pearson’s chi-
square with p = < 0.05 set for statistical significance.  Descriptive statistics describe the 
outcomes of clinical interest.  A Master’s student statistician from the University of New 
Hampshire was consulted as needed for guidance on analysis. 
Ethical Considerations 
The agency’s Institutional Review Board (IRB) approval and University of New 
Hampshire (UNH) IRB waiver were obtained prior to initiating the project.  All data were 
handled in accordance with Health Insurance Portability and Accountability Act of 1996 
(HIPAA) to protect the privacy of patients’ health information (DHHS, 2003).  Data were 
collected, maintained, and analyzed via Excel and OpenEpi (Dean, Sullivan & Soe, 2006).  
Aggregate data did not include potential patient identifiers.  All electronic medical records 
containing identifiable information, as well as de-identified data collected and maintained in 
Excel, were password protected to prevent access by unauthorized users.  Hard copy medical 
record information was accessed and maintained in accordance with the policies and procedures 
of the agency.  Electronic and hard copy medical records were only accessed by the Team 
Leader or agency employees who already had access to the data during the normal course of 
business for their role.  The statistician had access to the de-identified aggregate data only for the 
purposes of this project.  Protected health information (PHI) was not reused or disclosed to any 
other person or entity.  De-identified data will be maintained for 1 year after study completion, 
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then destroyed in accordance with the Department of Health and Human Services’ Guidelines for 
Responsible Data Management in Scientific Research (Coulehan & Wells, n.d.).  This research 
and quality improvement project posed no more than minimal risk to the subjects. 
A conflict of interest form and waiver of informed consent were submitted to the agency 
with the IRB application.  No conflicts of interest were identified.  This research could not be 
practicably conducted without a waiver as no identifiable patient information was maintained; 
and as a retrospective medical record review there was no direct contact with subjects. 
Clinical ethical considerations involve the use of PDHM in the healthy newborn based on 
clinical recommendations and inferred benefits from the literature despite extremely limited 
evidence on the risks and benefits of PDHM in this population.  However, to the knowledge of 
the Team Leader, no evidence exists of direct harm to a newborn, regardless of gestational age, 
through the use of PDHM. 
Results 
Evolution of the Intervention and Details of Process Measures 
 The steps involved in establishing a PDHM Program are outlined in Table 2.  While some 
portions of the project were completed in the expected timeline, most were completed 1 month 
behind schedule.  This was mainly due to lagging response times of individuals outside of the 
Team from whom approvals were required.  Despite the minor delays, the project was planned, 
implemented, studied, and initial improvement actions were taken (i.e., PDSA cycle) within the 
established timeframe of September 2017 to May 2018.  PDSA cycles will continue for quality 
improvement related to PDHM. 
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Table 2 
Intervention Timeline 
Task Sept  Oct Nov Dec Jan Feb Mar Apr May 
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IRB Submission & Approval/Waiver - UNH   X  O 
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Develop & Approve PDHM Policy, Patient 
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Cost Analysis to Obtain PDHM  X  
X  
O      
 
Train Staff   X  
 
O     
 
Order & Set Up of First PDHM   X   
 
O    
 
Implementation    X  
 
O    
 














Attempt to Receive Funding for Milk Warmer X  O 
X  










Note: X – Projected Timeline 
O – Actual Timeline 
 
Primary Measures 
Exclusive Breast Milk Feeding According to PC-05 & PC-05a. 
 Over the 6 month pre- and post-implementation period, a total of 325 births (pre-
implementation N=169, post-implementation N=156) occurred at the study agency.  Of those, 
287 newborns (88%) met inclusion criteria (pre- n=154, post- n=133) based on the JC’s PC-05 
metrics.  In the pre-implementation cohort, 104 out of 154 newborns (68%) were exclusively 
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breast milk fed.  Comparatively, 95 out of 133 newborns (71%) were exclusively breast milk fed 
in post-implementation.  Pearson’s chi-square analysis of the PC-05 metric, and resulting 3% 
rate increase, was not statistically significant (p = 0.47).  Of the families who chose breastfeeding 
on admission, 77% (n = 104/135) of the pre-implementation and 88% (n = 95/108) of the post-
implementation cohorts were considered exclusively breast milk fed using the JC’s retired metric 
PC-05a.  Pearson’s chi-square analysis revealed a statistically significant increase in exclusive 
breast milk feeding (p = 0.03). 
 Two likely explanations exist for the modest improvement in the PC-05 and PC-05a 
outcomes.  First, the short timeframe for data collection and analysis resulted in small sample 
sizes thus potentially skewing results.  Second, the 3 month timeframe for post-implementation 
data collection also coincided with the staff acclimating to the new PDHM processes.  As staff 
were learning the PDHM processes, there was the potential that patient eligibility for PDHM was 
mistaken thus potentially impacting the number of families who were offered or used PDHM.  
Longer pre- and post-implementation timelines for data collection would increase the sample 
sizes, and the inclusion of a washout period for staff acclimation, together may have further 
improved the results.  
Variables of Interest 
 Hours of Age at First Supplementation. 
The hours of newborn age at the time the first supplementation was received was 
calculated for each supplemented breastfed newborn (pre- n = 31, post n = 23).  Supplementation 
with both formula and PDHM were included in the calculation.  Figure 1 shows a comparison of 
the number of supplemented newborns between 0 – 72 hours of age, grouped into 12-hour 
blocks.  Variables that may have impacted this change in newborn age when first supplemented 
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are unknown though this warrants further investigation to better understand when mother-
newborn couplets are most vulnerable to the need or request for supplementation.
 
 
Figure 1. Newborn age at the time the first supplement was received in the pre- and post-implementation 
cohorts.  Graphs were produced in Plot.ly (2017). 
  
IMPLEMENTING DONOR HUMAN MILK 30 
Indications for Supplementation. 
Table 3 captures the indications for supplementation data.  During pre-implementation 
there was a 65% medical indication rate, a 47% rate of parent request for supplementation, and 
6% were unable to be determined.  Outcomes do not total 100% as several newborns had 
multiple indications for supplementation documented.  Four newborns of the pre-implementation 
cohort had both parent request and medical indications documented.  Ideally, newborn 
documentation would indicate supplementation based on either medical indications or non-
medical indications (i.e. parent request) but not both.  The post-implementation cohort had 65%, 
35%, and 0% rates respectively.  While the percent of medical indications for supplementation 
didn’t change, the results represent a relative decrease in parent requests (-12%) between the pre- 
and post- cohorts.  These outcomes could potentially be the result of targeted and repeated staff 
education regarding indications for supplementation which improved accuracy of documentation 
or potential evidence of a workaround. 
Table 3 
Indications for Supplementation 
Indication Pre- Post- Percent Change 
Medical 20/31 (65%) 15/23 (65%) 0% 
Contraindicated 1 1  
Dehydration 3 0  
Hyperbilirubinemia 3 4  
Hypoglycemia 1 3  
Low Supply as Only Indication 3 1  
Maternal Nipple Damage 3 1  
Mom Unavailable 1 0  
Poor Newborn Feeding 0 3  
Newborn Weight Loss 4 7  
Non-Medical    
Parent Request 13/31 (47%) 8/23 (35%) -12% 
Unable to Determine 2/31 (6%) 0 (0%) -6% 
Note: Percentages may not total 100% as some newborns had more than one indication for supplementation. 
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 Formula Supplementation of Breastfed Newborns in the First Two Days of Life. 
The pre- and post-implementation cohorts were compared on the breastfed newborns’ use 
of formula in the first two days of life.  These outcomes are based on HealthyPeople2020 
benchmarks which include the total population who was ever breastfed or fed breastmilk without 
exclusions.  For this project, all mothers who were undecided or chose breast or mixed feeding 
on admission without a contraindication to breastfeeding were included.  Newborns who were 
transferred were excluded from the calculation based on limited feeding data for this population.  
The pre-implementation cohort had a 23.2% rate of formula use in the first 2 days of life (n = 
33/142).  The post-implementation cohort had a 16.9% (n = 21/124) rate of formula use among 
breastfed newborns in the first two days of life.  The CDC’s Breastfeeding Report Card for 2016 
presented data on this metric, which was obtained from mPINC survey data, and reported a rate 
of formula use with breastfed newborns in the first two days of life of 17.1% nationally and 6.6% 
in the state of NH.  The HealthyPeople 2020 goal for this metric is 14.2% (HealthyPeople 2020, 
2017).  Although the change in the rate of formula use from pre- to post-implementation was not 
statistically significant (p = 0.20), the agency’s post-implementation rate of 16.9% nearly 
reached the HealthyPeople2020 goal for 2020 of 14.2% and surpassed the national rate of 17.1% 
(CDC, 2016; HealthyPeople 2020, 2017).  However, the agency has more work to do to reach the 
2020 goal and approach the average rate of formula use in the state of 6.6% which has 
implications in patient satisfaction and in remaining competitive in the marketplace. 
Contextual Elements and Unexpected Consequences 
 Figure 2 shows the proportion of feedings by supplement type.  Nine patients received 
PDHM in the post-implementation cohort and one patient received both PDHM and formula.  
This means an additional 7% (n = 9/133) of the post- PC-05 population were able to continue 
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     Pre-Implementation              Post-Implementation 
 
Figure 2. Proportion of newborns supplemented by type in each cohort.  Graphs were produced in Plot.ly (2017). 
 
Feeding choices on admission of families in the pre- and post-cohorts are displayed in 
Table 4.  Historically, the agency experienced a near 90% breastfeeding initiation rate, therefore 
the drop in rate for the PDHM group (pre- = 88%, post- = 81%) is unexpected and of interest.  
The reason families chose each feeding type was not collected; however, there is an increasing 
rate of maternal substance use which may be influencing this rate.  This is an area for future 
investigation in subsequent PDSA cycles. 
Table 4 
Feeding Choices on Admission in Pre- and Post- Cohorts 
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Of the JC defined breastfed newborn population, 23% in the pre-implementation cohort 
(n = 31/135) and 21% of the post-implementation cohort (n = 23/108) received supplementation 
of any type representing an interesting clinical trend.  Despite staff education regarding the risks 
of providing any supplement to breastfed newborns, such as negative impacts to maternal milk 
supply and the newborn’s latch at breast, a minimal change in the rate of supplementation was 
observed.  This highlights the need to assess staff and patients’ understanding, practices, and 
potential biases regarding supplementation of any type. 
Missing Data 
 Despite attempts to retrieve missing data, there were a few occasions when the data were 
unavailable from any source.  These were labeled “Unable to Determine” (UTD) per JC 
guidelines.  UTD data were calculated separately.  The missing data did not impact the 




 The primary aim of this quality improvement project was to implement a PDHM 
Program in a Level I nursery between September 2017 and May 2018 which was achieved.  The 
measured goal was to have an absolute increase of 10% in exclusive breastmilk feeding 
according to the JC’s Perinatal Core Measure for that outcome (PC-05).  With an absolute 
increase of 3%, this goal was not achieved.  However, when the data were measured according to 
the JC’s retired metric on exclusive breast milk feeding among the breastfeeding population (PC-
05a), an 11% increase was achieved with statistical significance (p=0.04). 
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Interpretation 
 The desired outcome of increasing exclusive breast milk feeding by 10% according to the 
JC’s PC-05 was not realized; although, a modest yet positive increase of 3% was observed.  
However, the post-implementation exclusive breast milk feeding rate of 71%, not only meets the 
JC’s suggested target for hospitals to strive to achieve but far exceeds the JC’s national average 
of 52.9% (JC, 2015).  Another successful outcome was the achievement of a statistically 
significant, 11% increase in exclusive breast milk feeding rates among breastfed newborns (PC-
05a).  The PC-05a measure allows for assessment of exclusive breast milk feeding while 
considering the feeding choices of the population.  Results of both PC-05 and PC-05a at the 
agency represent a positive trend that will continue to be monitored.  Increases in exclusive 
breast milk feeding in a well-baby population after implementation of PDHM were also reported 
by Belfort (2018) and Kair (2014). 
The tight project timeline included the immediate post-implementation period which was 
a time of continued and significant learning for the staff.  These post-implementation data may 
not be representative of the longer-term success of the program.  Marinelli et al (2014) and 
Utrera-Torres et al (2010) both completed before and after studies using PDHM in a NICU; and 
used data from 6 months pre-implementation and 6 months post-implementation with a washout 
period between (6 months and 8 months respectively) for implementation, education, and 
acclimation.  A prolonged data collection period may have resulted in different reporting 
outcomes. 
Staff reported that PDHM was well received by the patients; however, this is anecdotal 
and collecting data on staff and patient perceptions regarding PDHM is a recommendation for 
future exploration.  Kair and Flaherman (2017) found that mothers see PDHM as healthier and 
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temporary when compared to formula.  PDHM was also seen as unfamiliar, costly and 
logistically challenging (Kair & Flaherman, 2017).  When used before discharge, PDHM is 
covered 100% for patients by the agency thus removing the cost barrier in this setting.  The 
agency’s cost coverage also aligns with current regional practice as 95% of hospitals in the 
Northeast that provide PDHM to healthy newborns pay for it through the hospital budget (Belfort 
et al, 2018). 
Table 5 reflects the financial impact of the program; costs for implementation and the 
first 3 months of PDHM purchases are reflected.  The calculation does not account for the cost of 
time for project related work from the remainder of the Team or for staff to become educated.  
The Team experienced a greater than anticipated usage of PDHM in the 3 months following 
implementation.  Actual usage costs for PDHM in 3 months of $1,396.25 equates to an estimated 
annual expense of $5,585.  While these costs may not be offset directly, indirect savings to the 
hospital will likely be realized through increased patient satisfaction and decreased maternal and 
child morbidity and mortality.  At the end of 3 months post-implementation, the agency had a 
positive net balance of approximately $6,000 which is in excess of the estimated cost to purchase 
PDHM for 1 year.  Usage, costs to purchase milk and maintain the milk warmer, and outcomes 
data will continue to be collected by the Lactation Department. 
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Table 5 






Professional Time for DNP 
QI Project Management 
$10,500.00 $10,500.00 Financial savings based 
on 300 hours of unpaid 
service 
Equipment & Supply Cost: 
Commercial Grade Freezer 
-$3,000.00 -$2,478.60 This was obtained and 
paid for in a prior budget 
cycle 
    
Equipment & Supply Cost: 
Commercial Grade Milk 
Warmer 




    
Cost of PDHM + Shipping 
for First 3 Months 
-$650.00 -$1,396.25 This does not include 
milk sent and received 
via Replacement 
Agreements 
    
TOTAL SAVINGS $5,650 $6,103.75  
 
National economic cost analyses of suboptimal breastfeeding can be found in the 
literature.  Bartick et al (2017) modeled lifetime costs of suboptimal breastfeeding (i.e. for 
maternal ages 15 to 70 and from birth to 20 years of age for children) for a cohort of 1.9 million 
women and 3.75 million children including direct and indirect medical costs, non-medical costs, 
and premature death in 2014 U.S. dollars for the top 5 maternal and 9 childhood diseases 
impacted by breastfeeding which are listed in Table 6.  In this 2017 study, Bartick et al reported 
maternal and child costs totaling $18.5 billion.  It was also estimated that the number of women 
needed to breastfeed optimally to prevent 1 incidence of disease were 0.8 for gastrointestinal 
illness, 3 for acute otitis media, 95 for lower respiratory tract infection hospitalization, 55 for 
maternal hypertension, 162 for diabetes, and 235 for myocardial infarction (Bartick et al., 2017). 
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Table 6 
Top Diseases Impacted by Breastfeeding Reported by Bartick et al. 
Pediatric 
Acute lymphoblastic leukemia 




Lower respiratory tract infection requiring hospitalization 
Necrotizing enterocolitis 
Obesity in non-Hispanic whites 
Sudden Newborn Death Syndrome 
Maternal 
Breast cancer 
Pre-menopausal ovarian cancer 
Type II diabetes mellitus 
Hypertension 
Myocardial infarction 
Note: As reported in the study by Bartick et al. (2016) 
 
 Based on the same simulation reported by Bartick et al. (2017), Stube et al (2017) go on 
to estimate that an absolute increase of 5% in any and exclusive breastfeeding would result in a 
$44 million lifetime savings for the medical costs of childhood otitis media and gastrointestinal 
illness alone.  A 5% absolute increase in breastfeeding rates would result in a total savings of 
$1.9 billion when considering direct and indirect medical, non-medical, and premature death 
costs for mothers and children (Stube et al, 2017).  Therefore, investing in effective practices 
supporting breastfeeding, such as the BFHI and the Ten Steps, is considered a cost-effective 
strategy (Stube et al, 2017). 
Limitations 
Strong leadership support for PDHM was in place before the Team Leader assumed 
responsibility for this project.  Barriers to PDHM implementation were primarily the lack of staff 
and provider knowledge about the benefits of, and workflow for, PDHM.  Through impromptu 
conversations with staff, there appears to be a small cluster of staff who are not supportive of 
PDHM for fear of infection transmission to the newborn despite evidence to the contrary.  
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Additionally, there is a culture of nonchalance in formula supplementation of breastfed newborns 
among a portion of both nurses and physicians despite the evidence against this practice unless 
medically necessary.  Both of these barriers will need to be addressed to better understand the 
culture related to formula supplementation of breastfed newborns and any barriers to the use of 
PDHM. 
Based on new reporting requirements at the study agency that coincided with this project 
implementation, PC-05 data abstraction will be ongoing.  This will continue to inform practices 
related to exclusive breast milk feeding and the success or failure of the PDHM Program.  
Anecdotally, patients and staff have shared primarily positive feedback on the availability and 
use of PDHM.  Surveying staff and patients about feelings and experiences regarding 
supplementation and the use of PDHM would provide data to establish a more global 
understanding of the success or failure of the program and areas for future quality improvement 
efforts.  Additionally, patient satisfaction measured through Press Ganey data may begin to 
reflect patients’ experience with PDHM. 
 Quality improvement data is not intended to be generalizable outside of the study agency.  
The generalizability of this report to the agency is limited by the small sample size, specific 
population of interest, and limited statistical analysis.  Potential threats to internal validity were 
also identified.  The short timeline of post-implementation data collection meant that staff were 
still learning how and when to use PDHM.  Other studies of PDHM and exclusivity use a total of 
12 months of data, rather than 6 months, and a washout period to staff acclimation to the new 
process.  Increasing the length of pre- and post-implementation with a washout period may 
increase the internal validity and statistical significance of the outcome. 
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It is also possible that the staff education about PDHM and supplementation prior to 
implementation may have skewed the pre-implementation data as staff became more 
knowledgeable and conscientious about the risks of supplementing breastfed newborns.  
Additionally, human manipulation of data, the necessity of using multiple data sources and 
system limitations all present the possibility of errors.  Efforts to minimize errors involved spot 
checks in redundant systems, and comparison of data with the Quality department for accuracy.  
Confounding variables were not adjusted for and may include primiparity, use of glucose-gel in 
hypoglycemic newborns, staff attitudes, and patient attitudes.  Time constraints limited the 
ability to collect associated data and adjust for these variables. 
Conclusions 
Despite overwhelming evidence on the benefits of exclusive breastfeeding, national rates 
of exclusivity and those within the agency, require improvement to meet benchmarks.  The “Ten 
Steps to Successful Breastfeeding”, promoted through The Baby-Friendly Hospital Initiative 
(BFHI), are evidence-based maternity care practices that support breastfeeding.  Step 6 of the 
Ten Steps is to “give newborns no food or drink other than breast-milk unless medically 
indicated,” (BFHI, n.d.; WHO/UNICEF, 2009).  Likewise, HealthyPeople 2020 (2017) 
established a goal to reduce formula use in the first two days of life to 14.2% in 2020.  Based on 
improved health outcomes for mothers and newborns who breastfeed, among other rationales, 
the agency aimed to increase exclusive breastfeeding rates by 10%, as calculated by the JC 
reporting requirements of PC-05 (2017), within 3 months after implementation of a PDHM 
program.  Based on PC-05 metrics, the agency experienced a 3% increase in exclusive breast 
milk feeding which was modest and not statistically significant; however, indicates a positive 
trend toward the initial goal.  Success was realized in the breastfeeding population who 
IMPLEMENTING DONOR HUMAN MILK 40 
experienced a statistically significant 11% increase in exclusive breast milk feeding and the 
overall exclusive breast milk feeding rate of 71% which exceeds the JC’s recommended goal. 
When birthing facilities support exclusive breastfeeding in the inpatient setting; they are 
also promoting breastfeeding success for patients beyond their hospitalization.  In the face of 
medically necessary supplementation and an insufficient maternal milk supply, families now 
have an option to meet their newborn’s nutritional needs while maintaining exclusive breast milk 
feeding at the agency.  This practice has the potential for long-term, positive outcomes for both 
mothers and newborns. 
Funding 
No funding was obtained to implement this quality improvement project; however, 
several avenues were explored to obtain funding for the purchase of a milk warmer to improve 
the nursing workflow in the preparation of PDHM.  Initial efforts to obtain grant funding were 
unsuccessful; however, charitable funding was secured in April 2018 through the agency’s 
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